Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
Elisabetta ChessaMatteo PigaAlberto FlorisMattia CongiaIgnazio CangemiAlessandro MathieuAlberto CauliPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
Biologics and ts-drugs can cause IGDs. These events are rare, and the causative effect of a specific drug is hard to establish. When a patient is suspected of having an IGD, the drug should be discontinued, and treatment for the new-onset renal disorder should be promptly started.